Biosenta Inc. Ceases Negotiations With Voran Group Ventures Ltd.
Biosenta Inc. Ceases Negotiations With Voran Group Ventures Ltd.
CALGARY, Alberta, May 31, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. ( "Biosenta") (CSE: ZRO) announces that, further to its news release dated October 12, 2022, it has ceased negotiations with Voran Group Ventures Ltd. in respect of the previously announced Memorandum of Understanding dated October 5, 2022, for the commercialization of Biosenta's Tri-Filler antimicrobial products in Canadian markets and worldwide.
阿爾伯塔省卡爾加裡，2023年5月31日(環球通訊社)Biosenta Inc.(“Biosenta”)(CSE：ZRO)宣佈，繼於2022年10月12日發佈新聞稿後，已停止與Voran Group Ventures Ltd.就先前於2022年10月5日宣佈的諒解備忘錄的談判，該諒解備忘錄是關於Biosenta的Tri-Filler抗菌產品在加拿大市場和全球市場的商業化。
About Biosenta Inc.
關於 Biosenta Inc.
Biosenta is a Canadian-based company that develops and manufactures a range of safe and environmentally sound chemical compounds for household and industrial applications.
Biosenta是一家總部位於加拿大的公司，開發和製造一系列用於家庭和工業應用的安全和環境無害的化合物。
Disclaimer
免責
The CSE has in no way passed upon the contents of this news release and further, has neither approved nor disapproved of the contents of this news release. Neither the CSE nor its Regulation Services Provider (as such term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
中證所對本新聞稿的內容絕不過問，對本新聞稿的內容既不批准也不反對。CSE及其監管服務提供商(該術語在CSE的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
For Further Information please contact:
為 進一步 資訊 請 聯繫方式：
Am Gill, President and CEO of Biosenta Inc. am@biosenta.com
我是吉爾，總裁，Biosenta Inc.首席執行官。郵箱：am@biosenta.com
譯文內容由第三人軟體翻譯。